PATEL SUJAL M (CEO, President, and Secretary) purchased 0.8% of their position (77.23K shares) of NAUTILUS BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $76.9K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/21/2025ACC: 0001808805-25-000034
DirectorOfficer10% Owner· CEO, President, and Secretary
Since Jun 2021
+77.23K
Net shares
Net buyer
$76.9K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
77.23K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+53.30K
Price / share
$0.99
Trade value
$53.03K
% of position
0.5%
3/19/2025
10.06M→10.12M
Common Stock
Direct
Shares
+23.93K
Price / share
$1.00
Trade value
$23.89K
% of position
0.2%
3/20/2025
10.12M→10.14M
Total
Net shares
+77.23K
Net value
$76.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/19/2025 | P · Purchase | +53.30K | $0.99 | $53.03K | 0.5% | 10.06M | 10.12M |
| Common Stock Direct | 3/20/2025 | P · Purchase | +23.93K | $1.00 | $23.89K | 0.2% | 10.12M | 10.14M |
| Total | +77.23K | $76.92K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned5.28M
Common Stock
IndirectShares owned1.81M
Total
7.09M indirect7.09M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.28M | Indirect |
| Common Stock | 1.81M | Indirect |
| Total | 7.09M | 7.09M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported